Sean McCutcheon
Stock Analyst at Raymond James
(2.49)
# 2,424
Out of 5,143 analysts
12
Total ratings
33.33%
Success rate
9.95%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sean McCutcheon
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BBOT BridgeBio Oncology Therapeutics | Initiates: Outperform | $24 | $10.32 | +132.56% | 1 | Jan 9, 2026 | |
| RVMD Revolution Medicines | Maintains: Strong Buy | $72 → $76 | $104.83 | -27.50% | 2 | Oct 17, 2025 | |
| VIR Vir Biotechnology | Initiates: Outperform | $12 | $9.49 | +26.45% | 1 | Jul 11, 2025 | |
| JANX Janux Therapeutics | Initiates: Outperform | $65 | $13.65 | +376.19% | 1 | Jul 11, 2025 | |
| CMPX Compass Therapeutics | Reinstates: Outperform | $9 | $6.00 | +50.00% | 1 | Jul 1, 2025 | |
| BDTX Black Diamond Therapeutics | Reinstates: Outperform | $11 | $2.55 | +331.37% | 1 | Jul 1, 2025 | |
| ENGN enGene Holdings | Initiates: Outperform | $23 | $9.78 | +135.17% | 1 | Nov 27, 2024 | |
| XNCR Xencor | Maintains: Strong Buy | $58 → $40 | $11.81 | +238.70% | 1 | Jun 14, 2024 | |
| CYTK Cytokinetics | Maintains: Outperform | $92 → $70 | $70.10 | -0.14% | 2 | May 23, 2024 | |
| LEGN Legend Biotech | Initiates: Outperform | $86 | $19.50 | +341.03% | 1 | Mar 13, 2024 |
BridgeBio Oncology Therapeutics
Jan 9, 2026
Initiates: Outperform
Price Target: $24
Current: $10.32
Upside: +132.56%
Revolution Medicines
Oct 17, 2025
Maintains: Strong Buy
Price Target: $72 → $76
Current: $104.83
Upside: -27.50%
Vir Biotechnology
Jul 11, 2025
Initiates: Outperform
Price Target: $12
Current: $9.49
Upside: +26.45%
Janux Therapeutics
Jul 11, 2025
Initiates: Outperform
Price Target: $65
Current: $13.65
Upside: +376.19%
Compass Therapeutics
Jul 1, 2025
Reinstates: Outperform
Price Target: $9
Current: $6.00
Upside: +50.00%
Black Diamond Therapeutics
Jul 1, 2025
Reinstates: Outperform
Price Target: $11
Current: $2.55
Upside: +331.37%
enGene Holdings
Nov 27, 2024
Initiates: Outperform
Price Target: $23
Current: $9.78
Upside: +135.17%
Xencor
Jun 14, 2024
Maintains: Strong Buy
Price Target: $58 → $40
Current: $11.81
Upside: +238.70%
Cytokinetics
May 23, 2024
Maintains: Outperform
Price Target: $92 → $70
Current: $70.10
Upside: -0.14%
Legend Biotech
Mar 13, 2024
Initiates: Outperform
Price Target: $86
Current: $19.50
Upside: +341.03%